Background: Immediate postabortal intrauterine device (IUD) insertion decreases rates of repeat abortions. However, only one third of high-volume, non-hospital abortion providers in the United States offer immediate postabortal IUD placement. Study Design: We conducted a cost analysis from a public payer perspective to evaluate the potential cost savings associated with a policy of immediate postabortal ...Read more >

While most states have enacted legislation requiring that commercial insurance cover telemedicine, only a few require that payers reimburse telemedicine services at the same rate as in-person services. Because ‘reimbursement parity’ laws may remove financial disincentives for offering telemedicine, providers in states that require parity are likely better positioned to respond to the unprecedented demand ...Read more >

Planned Parenthood of Illinois (PPIL) is a critical safety net provider, delivering > 42,000 contraceptive visits per year across the state. Starting in March 2020, in response to the COVID-19 pandemic and the need to maintain patient access to care while reducing in-person contact, PPIL consolidated its in-person sites and began implementing rapid innovations in ...Read more >

I am currently an Associate Professor in the Department of Obstetrics and Gynecology at Wake Forest School of Medicine in Winston-Salem, NC, where I am able to balance my passions for women’s health care and medical education. I came to Wake Forest just after completing an OB/GYN residency and Maternal-Fetal Medicine fellowship at the Mayo ...Read more >

After I finished my undergraduate degree at Santa Clara University in California, I moved to Boston where I completed my medical school training at Boston University School of Medicine. I was fortunate to stay at Boston Medical Center for my residency in Obstetrics and Gynecology, a department that had both strong Maternal Fetal Medicine (MFM) ...Read more >

I am an Associate Professor of Obstetrics and Gynecology, Director of Obstetrical Services, and Vice Chair for Quality and Safety with appointments in the Center for Clinical Epidemiology and Biostatistics and the Leonard Davis Institute of Health Economics at the University of Pennsylvania. I have developed a successful research program in Maternal Fetal Medicine that ...Read more >

I am a womanist theo-ethicist/reproductive justice (RJ) expert whose scholarship is situated at the intersections of womanist theology and ethics and reproductive justice. I am one of the founding mothers of the RJ movement. This study examines the ways in which religious doctrine and dogma impact the reproductive decisions and sexual attitudes and behaviors of ...Read more >

Background: Current regulations restrict access to medication abortion and contribute to the perception that women cannot safely take medication abortion pills (mifepristone and misoprostol) on their own without clinician supervision. However, these drugs meet many of the Food and Drug Administration (FDA) criteria for being available over the counter (OTC). Medication abortion is safe, has ...Read more >

Background: While mifepristone has the potential to expand abortion access in the US through integration into primary care, initial expectations for provision by family physicians have not been realized. Research indicates that physician motivation to provide medication abortion is an important factor in overcoming logistical and organizational barriers to abortion provision. Methods: For this project, ...Read more >

Background: A rapid increase in legislation restricting access to clinical abortion services in the US has sparked renewed interest in self-managed abortion as a response to clinic access barriers. At the same time, rising interest in self-care and the role of the internet as a go-to source of goods and services raises the possibility that ...Read more >